FLT3-mutated AML: Biology and Treatment – Resonance

The ALRCaN Global webinar, “FLT3-Mutated AML: Biology and Treatment,” is scheduled for Friday, July 31, 2026, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT).
Presented by Mark J. Levis and organized by the Acute Leukemia Research and Care Network (ALRCaN), the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard, Stacy Cooper, Archie Bleyer, Dan Douer, and the Resonance Team.